OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+9.96%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$1.06B
AUM Growth
+$1.06B
Cap. Flow
+$338M
Cap. Flow %
31.93%
Top 10 Hldgs %
89.14%
Holding
24
New
5
Increased
Reduced
6
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NUVB icon
1
Nuvation Bio
NUVB
$1.02B
$295M 27.89% +28,212,376 New +$295M
REPL icon
2
Replimune Group
REPL
$422M
$153M 14.45% 5,008,245 -66,538 -1% -$2.03M
MORF
3
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$144M 13.6% 2,272,478 -649,293 -22% -$41.1M
KRON
4
DELISTED
Kronos Bio
KRON
$112M 10.57% 3,818,283
IMA
5
ImageneBio, Inc. Common Stock
IMA
$150M
$63.5M 6.01% +2,249,123 New +$63.5M
AVIR icon
6
Atea Pharmaceuticals
AVIR
$267M
$52.3M 4.95% 847,208
SPRB
7
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$35.9M 3.39% 2,161,022
GOSS icon
8
Gossamer Bio
GOSS
$562M
$30.7M 2.91% 3,320,608
IMUX icon
9
Immunic
IMUX
$80.9M
$28.5M 2.7% 1,788,160
SANA icon
10
Sana Biotechnology
SANA
$777M
$28.2M 2.67% +843,750 New +$28.2M
PRTK
11
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$18.4M 1.74% 2,600,410
ARQT icon
12
Arcutis Biotherapeutics
ARQT
$1.86B
$18M 1.71% 623,836 -16,363 -3% -$473K
CMPI
13
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$16.2M 1.53% 1,335,050
ALPN
14
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$13.6M 1.29% 1,284,900
SYRS
15
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$11.7M 1.11% 1,562,500
EPIX icon
16
ESSA Pharma
EPIX
$11.4M
$9.79M 0.93% 336,869 -368,824 -52% -$10.7M
CDTX icon
17
Cidara Therapeutics
CDTX
$1.66B
$5.33M 0.5% 2,005,249
OMEG
18
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$5M 0.47% +501,000 New +$5M
FGEN icon
19
FibroGen
FGEN
$47.8M
$4.54M 0.43% 130,646
TRVI icon
20
Trevi Therapeutics
TRVI
$883M
$3.42M 0.32% 1,263,408
OBSV
21
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.25M 0.31% 999,364
JNCE
22
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.83M 0.27% 275,513 -59,452 -18% -$611K
IMCR icon
23
Immunocore
IMCR
$1.62B
$2.19M 0.21% +51,535 New +$2.19M
PVLA
24
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$580K 0.05% 225,741 -525,000 -70% -$1.35M